---
title: "BAP1 Haploinsufficiency Predicts a Distinct Immunogenic Class of Malignant Peritoneal Mesothelioma"
authors:
- admin
- N Nabavi
- Y Lin
- F Mo
- S Anderson
- S Volik
- H H Adomat
- D Lin
- H Xue
- X Dong
- R Shukin
- RH Bell
- B McConeghy
- A Haegert
- S Brahmbhatt
- E Li
- HZ Oo
- A Hurtado-Coll
- L Fazli
- J Zhou
- Y McConnell
- A McCart
- A Lowy
- GB Morin
- T Chen
- M Daugaard
- SC Sahinalp
- F Hach
- S Le Bihan
- ME Gleave
- Y Wang
- A Churg 
- CC Collins 
author_notes:
- "Equal contribution"
- "Equal contribution"
date: "2019-02-07T00:00:00Z"
doi: "10.1186/s13073-019-0620-3"

# Schedule page publish date (NOT publication's date).
publishDate: "2019-02-07T00:00:00Z"

# Publication type.
# Accepts a single type but formatted as a YAML list (for Hugo requirements).
# Enter a publication type from the CSL standard.
publication_types: ["article"]

# Publication name and optional abbreviated publication name.
publication: "*Genome Medicine*"
publication_short: "*Genome Medicine*"

abstract: 

# Summary. An optional shortened abstract.
summary: Malignant peritoneal mesothelioma (PeM) is a rare and fatal cancer originating from the abdominal lining. Our study revealed that BAP1 could serve as a prognostic and predictive biomarker for immunotherapy in PeM.

tags:
- Cancer
- Mesothelioma
- Precision Oncology
featured: true

links:
 - name: Journal
   url: https://doi.org/10.1186/s13073-019-0620-3
 - name: PubMed
   url: https://www.ncbi.nlm.nih.gov/pubmed/30777124
 - name: Dataset2
   url: http://proteomecentral.proteomexchange.org/cgi/GetDataset?ID=PXD008873
 - name: Research Highlight
   url: https://genomemedicine.biomedcentral.com/articles/10.1186/s13073-019-0631-0   
url_pdf: https://genomemedicine.biomedcentral.com/counter/pdf/10.1186/s13073-019-0620-3.pdf
# url_code: 
url_dataset: https://www.ebi.ac.uk/ega/studies/EGAS00001002820
# url_poster: 
# url_project: 
# url_slides: 
# url_source: 
# url_video: 


# Featured image
# To use, add an image named `featured.jpg/png` to your page's folder. 
image:
  caption: ""
  focal_point: ""
  preview_only: false

# Associated Projects (optional).
#   Associate this publication with one or more of your projects.
#   Simply enter your project's folder or file name without extension.
#   E.g. `internal-project` references `content/project/internal-project/index.md`.
#   Otherwise, set `projects: []`.
projects: []

# Slides (optional).
#   Associate this publication with Markdown slides.
#   Simply enter your slide deck's filename without extension.
#   E.g. `slides: "example"` references `content/slides/example/index.md`.
#   Otherwise, set `slides: ""`.
slides: ""
---


<blockquote class="twitter-tweet" data-lang="en"><p lang="en" dir="ltr">Our paper describing a potentially new treatment for Peritoneal <a href="https://twitter.com/hashtag/Mesothelioma?src=hash&amp;ref_src=twsrc%5Etfw">#Mesothelioma</a> published today in <a href="https://twitter.com/GenomeMedicine?ref_src=twsrc%5Etfw">@GenomeMedicine</a>  <a href="https://t.co/admejVvX5K">https://t.co/admejVvX5K</a> <a href="https://twitter.com/VanProstateCtr?ref_src=twsrc%5Etfw">@VanProstateCtr</a> <a href="https://twitter.com/hashtag/PrecisionOncology?src=hash&amp;ref_src=twsrc%5Etfw">#PrecisionOncology</a> <a href="https://twitter.com/hashtag/Immunotherapy?src=hash&amp;ref_src=twsrc%5Etfw">#Immunotherapy</a> <a href="https://twitter.com/hashtag/Cancer?src=hash&amp;ref_src=twsrc%5Etfw">#Cancer</a> <a href="https://twitter.com/hashtag/Genomics?src=hash&amp;ref_src=twsrc%5Etfw">#Genomics</a> (1/n) <a href="https://t.co/mWrsjpTsr1">pic.twitter.com/mWrsjpTsr1</a></p>&mdash; Raunak Shrestha (@raunakms) <a href="https://twitter.com/raunakms/status/1097516525865431041?ref_src=twsrc%5Etfw">February 18, 2019</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>

<blockquote class="twitter-tweet" data-lang="en"><p lang="en" dir="ltr">Great to see our work ( <a href="https://t.co/admejVvX5K">https://t.co/admejVvX5K</a> ) making a mark in the field. Thanks <a href="https://twitter.com/MLadanyi?ref_src=twsrc%5Etfw">@MLadanyi</a> <a href="https://twitter.com/fsanchezvega?ref_src=twsrc%5Etfw">@fsanchezvega</a> <a href="https://twitter.com/MGZauderer?ref_src=twsrc%5Etfw">@MGZauderer</a> for highlighting our work.  <a href="https://t.co/s1cTVs2TgD">https://t.co/s1cTVs2TgD</a> <a href="https://twitter.com/hashtag/Mesothelioma?src=hash&amp;ref_src=twsrc%5Etfw">#Mesothelioma</a> <a href="https://twitter.com/hashtag/PeritonealMesothelioma?src=hash&amp;ref_src=twsrc%5Etfw">#PeritonealMesothelioma</a> <a href="https://twitter.com/hashtag/Immunotherapy?src=hash&amp;ref_src=twsrc%5Etfw">#Immunotherapy</a></p>&mdash; Raunak Shrestha (@raunakms) <a href="https://twitter.com/raunakms/status/1110969391925989377?ref_src=twsrc%5Etfw">March 27, 2019</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>


